Business Wire

Greene Tweed Receives Patent for Rapid Gas Decompression-Resistant Fluoroelastomers and Molded Articles

Share

The U.S. Patent Office has awarded Greene Tweed Patent Number 10,011,690 for Rapid Gas Decompression-Resistant Fluoroelastomer Compositions and Molded Articles. The innovative elastomer technology was developed by a team that included inventor Ron Campbell, PhD, Principal Scientist and Technology Leader for Elastomers in Greene Tweed’s Advanced Technology Group, to provide a competitive advantage in the Energy market and expand technology protected under a previous patent.

Rapid gas decompression (RGD) often occurs when high-pressure gas molecules migrate into an elastomer at a compressed state. When the pressure surrounding the elastomer is suddenly released, the compressed gas inside the elastomer tries to expand and exit the elastomer, thus causing RGD (also known as explosive decompression). Most elastomers experience severe blistering or cracking when the force of these expanding gases overcome the strength of the surrounding material; however, materials engineered to withstand RGD are more likely to maintain their integrity in the application.

RGD-resistant elastomers are widely used as seals and gaskets in compressors and down-hole applications where seals could encounter long soak times in high-pressure gases. Leaks and excessive cracking can lead to unnecessary downtime associated with unplanned maintenance, causing health, safety, and environmental issues and significant lost production time.

RGD-resistant elastomeric seals are generally optimized for seal designs with cross-sectional diameters less than 5.44 millimeters. This patent protects Greene Tweed’s technology for compounding and curing fluorocarbon elastomer seals with cross-sections that approach or exceed 10 millimeters, enabling us to offer superior reliability in larger seal cross-sections exposed to RGD environments.

The International Standards Organization’s ISO 23936-2:2011(E) and NORSOK M-710 serve as Oil & Gas industry benchmarks for RGD resistance. ISO and NORSOK also evaluate seal performance in an RGD environment.

Greene Tweed’s NORSOK M-710 and ISO 23936-2:2011 qualified materials include Chemraz® 526, 678, and 566, and Fusion™ FKM 938 and 944.

For more information, click here.

About Greene Tweed

Greene Tweed is a leading global manufacturer of high-performance seals and engineered components.

With 150+ years of technical expertise and commercial knowledge in a variety of markets, Greene Tweed collaborates with customers to develop innovative solutions that meet challenging performance requirements and reduce total cost of ownership.

We offer worldwide design and manufacturing expertise, solving your critical challenges through the development of custom-designed, leading-edge components.

Greene Tweed products are sold and distributed worldwide.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Greene Tweed
Chris Aldred
Corporate Marketing
+1.267.932.5389
caldred@gtweed.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Digital Health Leaders Meet at HIMSS24 Europe to Deliver Solutions to Tomorrow’s Healthcare Challenges24.4.2024 09:03:00 CEST | Press release

To address Europe’s most pressing healthcare challenges, Europe's longest-running, most influential digital health conference returns in 2024, bringing together innovators to shape tomorrow’s healthcare. The HIMSS24 European Health Conference & Exhibition will occur from 29-31 May at the Centro Congressi Roma La Nuvola in Rome, Italy. The conference will be the epicenter for pan-European collaborations and innovation, featuring thought leaders and healthcare professionals working together to create the best technology solutions across the digital health landscape. HIMSS24 Europe will feature programming focused on major global health challenges. Experts will lead discussions on how Europe uses data analytics, artificial intelligence, cybersecurity, and other cutting-edge technologies to address universal issues like health equity, patient privacy, access to care, workforce burnout, staffing shortages, and climate change. Registration is open for HIMSS24 Europe, and interested journalis

Kalray Joins Arm Total Design, Extending Collaboration With Arm on Accelerated AI Processing24.4.2024 09:01:00 CEST | Press release

Kalray (Euronext Growth Paris: ALKAL), a leading provider of hardware and software solutions to accelerate data intensive workflows from Cloud to Edge, announced that it has extended its collaboration with Arm by joining Arm Total Design. Through a deeper connection to industry leaders who are leveraging Arm® Neoverse™ Compute Subsystems (CSS), Kalray can help more companies integrate its unique AI and data acceleration technology and help Arm ecosystem partners commercialize AI-based solutions in a fraction of the time and cost usually needed. Arm Total Design helps accelerate and simplify the delivery of custom silicon based on Arm Neoverse CSS and has grown to more than 20 partners, including the top three leading foundries, ASIC design houses, IP vendors, EDA tool providers, and firmware developers who are driving leading-edge innovation. Kalray is already working to integrate Arm Coherent Mesh Network (CMN) technology to help easily connect Kalray’s advanced AI and data processing

Suzano Ventures invests up to US$5 million into Bioform Technologies to further develop bio-based plastic alternatives24.4.2024 09:01:00 CEST | Press release

Suzano Ventures, the corporate venture capital arm of Suzano, the world’s largest market pulp producer, has made a strategic investment into the Canadian materials science startup, Bioform Technologies. The investment provides up to US$5 million towards the company’s seed round, enabling it to accelerate the development of its novel bio-based plastic alternatives. The products can be manufactured through modified industrial processes already used in the pulp and paper sector. Bioform’s proprietary technology rapidly produces wood pulp-reinforced hydrogels to create high-performance plastic alternatives, which can be made using Suzano’s wood pulp fibre as a key input. Bioform’s materials have the potential to be home compostable or recycled through existing paper recycling processes and do not require fossil-based inputs. The technology is highly versatile and has a number of applications where it could replace conventional single-use plastics, including paper recyclable thermoformable

SES’s O3b mPOWER System Starts Providing High-performance Connectivity Services24.4.2024 08:50:00 CEST | Press release

SES announced today that O3b mPOWER, its second-generation software-enabled satellite system, is now operational and can provide high-performance connectivity services around the globe. With the first six O3b mPOWER satellites operating at medium Earth orbit (MEO) or 8,000km away from the Earth and with extensive ground infrastructure built around the world, SES will be introducing services in the coming months to O3b mPOWER customers to deliver reliable connectivity services ranging from tens of Mbps to multiple gigabits per second. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240423122963/en/ SES’s O3b mPOWER System Starts Providing High-performance Connectivity Services (Photo: Business Wire) To date, SES has launched six out of 13 O3b mPOWER high-throughput and low-latency satellites, which together with strategically located satellite ground stations, enable SES to serve customers across multiple market segments aroun

Galderma Delivers a Strong Start to the Year With Record Net Sales of Over 1 Billion USD for the First Quarter and 12.4% Year-on-Year Growth24.4.2024 07:00:00 CEST | Press release

Galderma Group AG (SWX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2024. Record net sales of 1.071 billion USD in the first quarter of 2024, surpassing for the first time the 1 billion USD mark for the first three months in a year Net sales growth for the first quarter of 2024 was 12.4% year-on-year on a constant currency basis1, primarily driven by volume Broad-based growth across all product categories, with constant currency year-on-year growth of 19.3% for Injectable Aesthetics, 8.4% for Dermatological Skincare, and 4.1% for Therapeutic Dermatology Growth across geographies, especially in International markets while U.S. growth accelerated year-on-year 2024 full year guidance confirmed: 7-10% net sales year-on-year growth at constant currency and Core EBITDA margin in line with 2023 at constant currency Continued execution of Galderma’s integrated dermatology strategy, progressing on its innovation pipeline, comme

HiddenA line styled icon from Orion Icon Library.Eye